BioNexus Gene Lab Corp. (BGLC)
2.32
-0.31 (-11.79%)
At close: Apr 14, 2025, 3:59 PM
2.15
-7.33%
After-hours: Apr 14, 2025, 07:58 PM EDT
-11.79% (1D)
| Bid | 2.1 |
| Market Cap | 4.17M |
| Revenue (ttm) | 9.26M |
| Net Income (ttm) | -942.61K |
| EPS (ttm) | -0.61 |
| PE Ratio (ttm) | -3.8 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.22 |
| Volume | 374,281 |
| Avg. Volume (20D) | 611,489 |
| Open | 2.28 |
| Previous Close | 2.63 |
| Day's Range | 2.29 - 2.75 |
| 52-Week Range | 2.01 - 10.00 |
| Beta | 1.76 |
About BGLC
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and pro...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jan 8, 2021
Employees 30
Stock Exchange NASDAQ
Ticker Symbol BGLC
Website https://www.bionexusgenelab.com
7 months ago
+2.83%
BioNexus Gene Lab shares are trading higher after ...
Unlock content with
Pro Subscription
7 months ago
+4.27%
BioNexus Gene Lab shares are trading higher after the company announced a $228K investment in Ascension Innovation Sdn Bhd.
